Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 411 entries
Sorted by: Best Match Show Resources per page
Erratum to: Which play a more important role in the development of large-sized prostates (≥80 ml), androgen receptors or oestrogen receptors? A comparative study.

International urology and nephrology

Zhang P, Hu WL, Cheng B, Zeng YJ, Wang XH, Liu TZ, Zhang WB.
PMID: 27334751
Int Urol Nephrol. 2016 Sep;48(9):1467. doi: 10.1007/s11255-016-1343-7.

No abstract available.

Cite
Zhang P, Hu WL, Cheng B, et al. Erratum to: Which play a more important role in the development of large-sized prostates (≥80 ml), androgen receptors or oestrogen receptors? A comparative study. Int Urol Nephrol. 2016;48(9):1467doi: 10.1007/s11255-016-1343-7.
Zhang, P., Hu, W. L., Cheng, B., Zeng, Y. J., Wang, X. H., Liu, T. Z., & Zhang, W. B. (2016). Erratum to: Which play a more important role in the development of large-sized prostates (≥80 ml), androgen receptors or oestrogen receptors? A comparative study. International urology and nephrology, 48(9), 1467. https://doi.org/10.1007/s11255-016-1343-7
Zhang, Peng, et al. "Erratum to: Which play a more important role in the development of large-sized prostates (≥80 ml), androgen receptors or oestrogen receptors? A comparative study." International urology and nephrology vol. 48,9 (2016): 1467. doi: https://doi.org/10.1007/s11255-016-1343-7
Zhang P, Hu WL, Cheng B, Zeng YJ, Wang XH, Liu TZ, Zhang WB. Erratum to: Which play a more important role in the development of large-sized prostates (≥80 ml), androgen receptors or oestrogen receptors? A comparative study. Int Urol Nephrol. 2016 Sep;48(9):1467. doi: 10.1007/s11255-016-1343-7. PMID: 27334751.
Copy Download .nbib Format: NLM
Nocturia and mortality in male patients with type 2 diabetes mellitus.

International urology and nephrology

Kawada T.
PMID: 27832400
Int Urol Nephrol. 2017 Feb;49(2):271-272. doi: 10.1007/s11255-016-1459-9. Epub 2016 Nov 10.

No abstract available.

Cite
Kawada T. Nocturia and mortality in male patients with type 2 diabetes mellitus. Int Urol Nephrol. 2016;49(2):271-272doi: 10.1007/s11255-016-1459-9.
Kawada, T. (2017). Nocturia and mortality in male patients with type 2 diabetes mellitus. International urology and nephrology, 49(2), 271-272. https://doi.org/10.1007/s11255-016-1459-9
Kawada, Tomoyuki. "Nocturia and mortality in male patients with type 2 diabetes mellitus." International urology and nephrology vol. 49,2 (2017): 271-272. doi: https://doi.org/10.1007/s11255-016-1459-9
Kawada T. Nocturia and mortality in male patients with type 2 diabetes mellitus. Int Urol Nephrol. 2017 Feb;49(2):271-272. doi: 10.1007/s11255-016-1459-9. Epub 2016 Nov 10. PMID: 27832400.
Copy Download .nbib Format: NLM
Erratum to: A resting-state functional MRI study on central control of storage: brain response provoked by strong desire to void.

International urology and nephrology

Gao Y, Liao L, Blok BF.
PMID: 26187011
Int Urol Nephrol. 2015 Aug;47(8):1363. doi: 10.1007/s11255-015-1057-2.

No abstract available.

Cite
Gao Y, Liao L, Blok BF. Erratum to: A resting-state functional MRI study on central control of storage: brain response provoked by strong desire to void. Int Urol Nephrol. 2015;47(8):1363doi: 10.1007/s11255-015-1057-2.
Gao, Y., Liao, L., & Blok, B. F. (2015). Erratum to: A resting-state functional MRI study on central control of storage: brain response provoked by strong desire to void. International urology and nephrology, 47(8), 1363. https://doi.org/10.1007/s11255-015-1057-2
Gao, Yi, et al. "Erratum to: A resting-state functional MRI study on central control of storage: brain response provoked by strong desire to void." International urology and nephrology vol. 47,8 (2015): 1363. doi: https://doi.org/10.1007/s11255-015-1057-2
Gao Y, Liao L, Blok BF. Erratum to: A resting-state functional MRI study on central control of storage: brain response provoked by strong desire to void. Int Urol Nephrol. 2015 Aug;47(8):1363. doi: 10.1007/s11255-015-1057-2. PMID: 26187011.
Copy Download .nbib Format: NLM
Death with functioning kidney transplant: an obituarial analysis.

International urology and nephrology

Sood P, Zhu YR, Cohen EP.
PMID: 20521168
Int Urol Nephrol. 2010 Dec;42(4):929-34. doi: 10.1007/s11255-010-9721-z. Epub 2010 Jun 03.

BACKGROUND: Death with a functioning kidney graft (DWFG) is now a major cause of graft loss after renal transplantation, occurring in up to 40% of cases. Its occurrence provides insight into the medical care of subjects with a functioning...

Cite
Sood P, Zhu YR, Cohen EP. Death with functioning kidney transplant: an obituarial analysis. Int Urol Nephrol. 2010;42(4):929-34doi: 10.1007/s11255-010-9721-z.
Sood, P., Zhu, Y. R., & Cohen, E. P. (2010). Death with functioning kidney transplant: an obituarial analysis. International urology and nephrology, 42(4), 929-34. https://doi.org/10.1007/s11255-010-9721-z
Sood, Puneet, et al. "Death with functioning kidney transplant: an obituarial analysis." International urology and nephrology vol. 42,4 (2010): 929-34. doi: https://doi.org/10.1007/s11255-010-9721-z
Sood P, Zhu YR, Cohen EP. Death with functioning kidney transplant: an obituarial analysis. Int Urol Nephrol. 2010 Dec;42(4):929-34. doi: 10.1007/s11255-010-9721-z. Epub 2010 Jun 03. PMID: 20521168; PMCID: PMC2995205.
Copy Download .nbib Format: NLM
Treatment of asymptomatic hyperuricemia complicated by renal damage: a controversial issue.

International urology and nephrology

Hu C, Wu X.
PMID: 31463702
Int Urol Nephrol. 2019 Dec;51(12):2227-2233. doi: 10.1007/s11255-019-02256-5. Epub 2019 Aug 28.

The prevalence of asymptomatic HUA is increasing year after year. HUA is a risk factor for the occurrence and development of renal diseases. However, the role of urate-lowering therapy in asymptomatic HUA complicated by renal damage is still controversial....

Cite
Hu C, Wu X. Treatment of asymptomatic hyperuricemia complicated by renal damage: a controversial issue. Int Urol Nephrol. 2019;51(12):2227-2233doi: 10.1007/s11255-019-02256-5.
Hu, C., & Wu, X. (2019). Treatment of asymptomatic hyperuricemia complicated by renal damage: a controversial issue. International urology and nephrology, 51(12), 2227-2233. https://doi.org/10.1007/s11255-019-02256-5
Hu, Chun, and Wu, Xiaoyan. "Treatment of asymptomatic hyperuricemia complicated by renal damage: a controversial issue." International urology and nephrology vol. 51,12 (2019): 2227-2233. doi: https://doi.org/10.1007/s11255-019-02256-5
Hu C, Wu X. Treatment of asymptomatic hyperuricemia complicated by renal damage: a controversial issue. Int Urol Nephrol. 2019 Dec;51(12):2227-2233. doi: 10.1007/s11255-019-02256-5. Epub 2019 Aug 28. PMID: 31463702.
Copy Download .nbib Format: NLM
Re: Letter to the editor.

International urology and nephrology

Lebentrau S, Gilfrich C, Vetterlein MW, Schumacher H, Spachmann PJ, Brookman-May SD, Fritsche HM, Schostak M, Wagenlehner FM, Burger M, May M.
PMID: 29441478
Int Urol Nephrol. 2018 May;50(5):875. doi: 10.1007/s11255-018-1808-y. Epub 2018 Feb 13.

No abstract available.

Cite
Lebentrau S, Gilfrich C, Vetterlein MW, et al. Re: Letter to the editor. Int Urol Nephrol. 2018;50(5):875doi: 10.1007/s11255-018-1808-y.
Lebentrau, S., Gilfrich, C., Vetterlein, M. W., Schumacher, H., Spachmann, P. J., Brookman-May, S. D., Fritsche, H. M., Schostak, M., Wagenlehner, F. M., Burger, M., & May, M. (2018). Re: Letter to the editor. International urology and nephrology, 50(5), 875. https://doi.org/10.1007/s11255-018-1808-y
Lebentrau, Steffen, et al. "Re: Letter to the editor." International urology and nephrology vol. 50,5 (2018): 875. doi: https://doi.org/10.1007/s11255-018-1808-y
Lebentrau S, Gilfrich C, Vetterlein MW, Schumacher H, Spachmann PJ, Brookman-May SD, Fritsche HM, Schostak M, Wagenlehner FM, Burger M, May M. Re: Letter to the editor. Int Urol Nephrol. 2018 May;50(5):875. doi: 10.1007/s11255-018-1808-y. Epub 2018 Feb 13. PMID: 29441478.
Copy Download .nbib Format: NLM
Selected cardiovascular risk factors in early stages of chronic kidney disease.

International urology and nephrology

Jagieła J, Bartnicki P, Rysz J.
PMID: 31955363
Int Urol Nephrol. 2020 Feb;52(2):303-314. doi: 10.1007/s11255-019-02349-1. Epub 2020 Jan 18.

Cardiovascular diseases, including hypertension, congestive heart failure, myocardial infarction, stroke and atherosclerosis, are common in patients with chronic kidney disease. Aside from the standard biomarkers, measured to determine cardiovascular risk, new ones have emerged: markers of oxidative stress, apoptosis,...

Cite
Jagieła J, Bartnicki P, Rysz J. Selected cardiovascular risk factors in early stages of chronic kidney disease. Int Urol Nephrol. 2020;52(2):303-314doi: 10.1007/s11255-019-02349-1.
Jagieła, J., Bartnicki, P., & Rysz, J. (2020). Selected cardiovascular risk factors in early stages of chronic kidney disease. International urology and nephrology, 52(2), 303-314. https://doi.org/10.1007/s11255-019-02349-1
Jagieła, Joanna, et al. "Selected cardiovascular risk factors in early stages of chronic kidney disease." International urology and nephrology vol. 52,2 (2020): 303-314. doi: https://doi.org/10.1007/s11255-019-02349-1
Jagieła J, Bartnicki P, Rysz J. Selected cardiovascular risk factors in early stages of chronic kidney disease. Int Urol Nephrol. 2020 Feb;52(2):303-314. doi: 10.1007/s11255-019-02349-1. Epub 2020 Jan 18. PMID: 31955363.
Copy Download .nbib Format: NLM
Kidney biopsy findings in vancomycin-induced acute kidney injury: a pooled analysis.

International urology and nephrology

Bellos I, Pergialiotis V, Perrea DN.
PMID: 33715061
Int Urol Nephrol. 2022 Jan;54(1):137-148. doi: 10.1007/s11255-021-02831-9. Epub 2021 Mar 14.

BACKGROUND: Acute kidney injury represents a major adverse effect of vancomycin administration. The aim of the present study is to accumulate all biopsy-proven cases of vancomycin nephrotoxicity and assess the association of histopathological features with renal prognosis.METHODS: Medline, Scopus,...

Cite
Bellos I, Pergialiotis V, Perrea DN. Kidney biopsy findings in vancomycin-induced acute kidney injury: a pooled analysis. Int Urol Nephrol. 2021;54(1):137-148doi: 10.1007/s11255-021-02831-9.
Bellos, I., Pergialiotis, V., & Perrea, D. N. (2022). Kidney biopsy findings in vancomycin-induced acute kidney injury: a pooled analysis. International urology and nephrology, 54(1), 137-148. https://doi.org/10.1007/s11255-021-02831-9
Bellos, Ioannis, et al. "Kidney biopsy findings in vancomycin-induced acute kidney injury: a pooled analysis." International urology and nephrology vol. 54,1 (2022): 137-148. doi: https://doi.org/10.1007/s11255-021-02831-9
Bellos I, Pergialiotis V, Perrea DN. Kidney biopsy findings in vancomycin-induced acute kidney injury: a pooled analysis. Int Urol Nephrol. 2022 Jan;54(1):137-148. doi: 10.1007/s11255-021-02831-9. Epub 2021 Mar 14. PMID: 33715061.
Copy Download .nbib Format: NLM
Kidney biopsy findings in vancomycin-induced acute kidney injury: a pooled analysis.

International urology and nephrology

Bellos I, Pergialiotis V, Perrea DN.
PMID: 33715061
Int Urol Nephrol. 2022 Jan;54(1):137-148. doi: 10.1007/s11255-021-02831-9. Epub 2021 Mar 14.

BACKGROUND: Acute kidney injury represents a major adverse effect of vancomycin administration. The aim of the present study is to accumulate all biopsy-proven cases of vancomycin nephrotoxicity and assess the association of histopathological features with renal prognosis.METHODS: Medline, Scopus,...

Cite
Bellos I, Pergialiotis V, Perrea DN. Kidney biopsy findings in vancomycin-induced acute kidney injury: a pooled analysis. Int Urol Nephrol. 2021;54(1):137-148doi: 10.1007/s11255-021-02831-9.
Bellos, I., Pergialiotis, V., & Perrea, D. N. (2022). Kidney biopsy findings in vancomycin-induced acute kidney injury: a pooled analysis. International urology and nephrology, 54(1), 137-148. https://doi.org/10.1007/s11255-021-02831-9
Bellos, Ioannis, et al. "Kidney biopsy findings in vancomycin-induced acute kidney injury: a pooled analysis." International urology and nephrology vol. 54,1 (2022): 137-148. doi: https://doi.org/10.1007/s11255-021-02831-9
Bellos I, Pergialiotis V, Perrea DN. Kidney biopsy findings in vancomycin-induced acute kidney injury: a pooled analysis. Int Urol Nephrol. 2022 Jan;54(1):137-148. doi: 10.1007/s11255-021-02831-9. Epub 2021 Mar 14. PMID: 33715061.
Copy Download .nbib Format: NLM
Bladder cancer biomarker screening based on non-targeted urine metabolomics.

International urology and nephrology

Li J, Cheng B, Xie H, Zhan C, Li S, Bai P.
PMID: 34850327
Int Urol Nephrol. 2022 Jan;54(1):23-29. doi: 10.1007/s11255-021-03080-6. Epub 2021 Nov 30.

PURPOSE: Bladder cancer is one of the most common malignancies of the urinary system, and its screening relies heavily on invasive cystoscopy, which increases the risk of urethral injury and infection. This study aims to use non-targeted metabolomics methods...

Cite
Li J, Cheng B, Xie H, et al. Bladder cancer biomarker screening based on non-targeted urine metabolomics. Int Urol Nephrol. 2021;54(1):23-29doi: 10.1007/s11255-021-03080-6.
Li, J., Cheng, B., Xie, H., Zhan, C., Li, S., & Bai, P. (2022). Bladder cancer biomarker screening based on non-targeted urine metabolomics. International urology and nephrology, 54(1), 23-29. https://doi.org/10.1007/s11255-021-03080-6
Li, Jinkun, et al. "Bladder cancer biomarker screening based on non-targeted urine metabolomics." International urology and nephrology vol. 54,1 (2022): 23-29. doi: https://doi.org/10.1007/s11255-021-03080-6
Li J, Cheng B, Xie H, Zhan C, Li S, Bai P. Bladder cancer biomarker screening based on non-targeted urine metabolomics. Int Urol Nephrol. 2022 Jan;54(1):23-29. doi: 10.1007/s11255-021-03080-6. Epub 2021 Nov 30. PMID: 34850327.
Copy Download .nbib Format: NLM
Pretreatment morning urine osmolality and oral desmopressin lyophilisate treatment outcome in patients with primary monosymptomatic enuresis.

International urology and nephrology

Abdovic S, Cuk M, Hizar I, Milosevic M, Jerkovic A, Saraga M.
PMID: 33774753
Int Urol Nephrol. 2021 Aug;53(8):1529-1534. doi: 10.1007/s11255-021-02843-5. Epub 2021 Mar 27.

PURPOSE: To determine the association between urine osmolality (Uosm) in patients with primary monosymptomatic enuresis (PMNE) and response to desmopressin (dDAVP) lyophilisate.METHODS: This was a prospective cohort study that included 419 children with enuresis seen in outpatient clinic between...

Cite
Abdovic S, Cuk M, Hizar I, et al. Pretreatment morning urine osmolality and oral desmopressin lyophilisate treatment outcome in patients with primary monosymptomatic enuresis. Int Urol Nephrol. 2021;53(8):1529-1534doi: 10.1007/s11255-021-02843-5.
Abdovic, S., Cuk, M., Hizar, I., Milosevic, M., Jerkovic, A., & Saraga, M. (2021). Pretreatment morning urine osmolality and oral desmopressin lyophilisate treatment outcome in patients with primary monosymptomatic enuresis. International urology and nephrology, 53(8), 1529-1534. https://doi.org/10.1007/s11255-021-02843-5
Abdovic, S, et al. "Pretreatment morning urine osmolality and oral desmopressin lyophilisate treatment outcome in patients with primary monosymptomatic enuresis." International urology and nephrology vol. 53,8 (2021): 1529-1534. doi: https://doi.org/10.1007/s11255-021-02843-5
Abdovic S, Cuk M, Hizar I, Milosevic M, Jerkovic A, Saraga M. Pretreatment morning urine osmolality and oral desmopressin lyophilisate treatment outcome in patients with primary monosymptomatic enuresis. Int Urol Nephrol. 2021 Aug;53(8):1529-1534. doi: 10.1007/s11255-021-02843-5. Epub 2021 Mar 27. PMID: 33774753.
Copy Download .nbib Format: NLM
Chronic intermittent self-bladder catheterization with plastic funnel.

International urology and nephrology

Habek D.
PMID: 34378084
Int Urol Nephrol. 2021 Nov;53(11):2295-2296. doi: 10.1007/s11255-021-02977-6. Epub 2021 Aug 10.

No abstract available.

Cite
Habek D. Chronic intermittent self-bladder catheterization with plastic funnel. Int Urol Nephrol. 2021;53(11):2295-2296doi: 10.1007/s11255-021-02977-6.
Habek, D. (2021). Chronic intermittent self-bladder catheterization with plastic funnel. International urology and nephrology, 53(11), 2295-2296. https://doi.org/10.1007/s11255-021-02977-6
Habek, Dubravko. "Chronic intermittent self-bladder catheterization with plastic funnel." International urology and nephrology vol. 53,11 (2021): 2295-2296. doi: https://doi.org/10.1007/s11255-021-02977-6
Habek D. Chronic intermittent self-bladder catheterization with plastic funnel. Int Urol Nephrol. 2021 Nov;53(11):2295-2296. doi: 10.1007/s11255-021-02977-6. Epub 2021 Aug 10. PMID: 34378084.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 411 entries